Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
Coverage with evidence development (CED)
Critical care
See all tags

NHS Innovation Accelerator innovations selected as part of Health Data Research UK Sandbox

Outcomes Based Healthcare and My Diabetes My Way have been selected as Health Data Research UK (HDRUK) Sandbox projects.

The Sandbox program provides an environment for virtual testing of products, services, innovations, and knowledge that require access to large scale data to improve the health of patients and the population. The Sandbox will provide test cases for a government initiative, delivered by Health Data Research UK, to transform access to the UK’s health data – safely and securely – for research that could pioneer new and faster treatments for patients and find new cures for diseases. Seven test use cases were selected to participate.

Outcomes Based Healthcare is a population health analytics platform that measures ‘true’ health outcomes in near real-time. Fellow Rupert Dunbar-Rees was selected to join the NIA in 2016.

My Diabetes My Way was selected as an NIA innovation in 2017. It is a low-cost, scalable, comprehensive online self-management platform for people with diabetes.

See the full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

Tags
UK
Innovation funding
Diabetes
e-Health

The latest related news

20
Nov 2024

Ongoing mini-HTAs in Norway in November 2024

In November 2024, the following ongoing mini-HTA assessments for cardiovascular, diagnostic imaging, e-health, gastrointestinal, in-vitro diagnostics, interventional radiology, men’s health, pulmonary and airways, robotic surgery, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway.
Read more
14
Nov 2024

The "Subsidy scheme for promising care" will be discontinued in the Netherlands

In October 2024, the Ministry of Health, Welfare, and Sport decided to discontinue the "Subsidy scheme for promising care," which was implemented in 2019 to support the development of missing clinical and economic evidence for promising care that otherwise cannot be covered within basic health insurance. There are 28 ongoing projects, and some new projects will be awarded the subsidy in the 2025 round.
Read more
12
Nov 2024

Med Tech-related health technology assessments from NIHR in October 2024

In October 2024, the National Institute for Health and Care Research (NIHR) in England released seven Med Tech-related assessments in its HTA Journal, which concerned the Genedrive kit, timing of stoma closure in neonates, interventions in perceptual disorders after stroke, revascularisation strategy for chronic limb ischemia, MRI software and cognitive fusion biopsies in prostate cancer, transperineal prostate biopsy devices, and ultraviolet therapy in severe eczema. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs NICE guidance.
Read more
11
Nov 2024

Strategy for Life Science towards 2030 in Denmark

In November 2024, the Danish Government presented a new Strategy for Life Science towards 2030. The Strategy will strengthen the role of innovative health solutions in relation to freeing up labor and ensuring a sustainable healthcare system. The Vision is that Denmark must be a leading life science nation in Europe to benefit patients, the Danish healthcare system, and the Danish economy.
Read more